
Sacituzumab govitecan shows improved survival and quality of life in advanced triple-negative breast cancer, outperforming standard chemotherapy in recent trials.
Kevin Punie, MD, is a medical oncologist in the Department of General Medical Oncology at University Hospitals Leuven, Gasthuisberg.